Find an expert

Julie joined the University of Queensland as an Associate Professor in May 2023. Julie participated in designing the Journeys Home Survey, a longitudinal study of Australians who are homeless or at-risk of homelessness. Her current research revolves around a number of issues related to disadvantage in education, housing, health and labour economics. Specifically, she works on homelessness & precarious housing, substance use, incarceration, gender gaps in education, peer effects and female's labour market participation. Julie is developing a research agenda aiming to support the development of better opportunities for Indigenous Australians. This includes a project to evaluate the impact of Indigenous preferential procurement programs and a project on “Historical frontier violence: drivers, legacy and the role of truth-telling”, both supported by ARC funding.

Karin S. Moser's teaching and research focusses on human cooperation, communication and decision making, using both experimental and field study approaches. She is interested in understanding what characterises successful collaboration of individuals and teams across organisational and national borders, different cultural and social backgrounds, identities and interests, across situational and contextual constraints, and by various means and (digital) technologies.

For further information, check out the Moser Lab: www.karinmoser.net and her Orcid profile: https://orcid.org/0000-0003-0120-9327

Dr Philip Mosley studied at the University of Oxford and obtained a masters degree in physiological sciences and a degree in medicine. He was also captain of the university boxing team and was awarded two full 'Blues'. He worked as a junior doctor in Manchester before moving to Australia to complete his specialist training in psychiatry.

Dr Mosley is a Fellow of the Royal Australian and New Zealand College of Psychiatry (RANZCP) and has completed an advanced certificate in Consultation-Liaison Psychiatry. As part of his training he also undertook a 2-year neuropsychiatry fellowship at the Royal Brisbane and Women’s Hospital (RBWH) and the Asia-Pacific Centre for Neuromodulation (APCN) at the University of Queensland. Currently, Dr Mosley works as a member of the deep brain stimulation (DBS) team at St Andrew's War Memorial Hospital, Brisbane, runs a private neuropsychiatry practice and also provides a consultation-liaison psychiatry service to the neurology, medical and surgical wards. Dr Mosley's private practice is focussed on neurodegenerative disease, movement disorders and head injury.

Dr Mosley is an active clinician-scientist with appointments at the QIMR Berghofer Medical Research Institute, Queensland Brain Institute and CSIRO. He completed his PhD in neuroscience in 2019 under the supervision of Professor Michael Breakspear. He published eleven peer-reviewed manuscripts and received the UQ Dean's Award for outstanding thesis. Dr Mosley has been the chief investigator in a study of the neuropsychiatric effects of DBS for Parkinson’s disease, in a study of medicinal cannabis for Tourette’s syndrome, a lead investigator in a clinical trial of DBS for obsessive-compulsive disorder and anorexia nervosa, as well as a clinical fellow in a neuroimaging study of Alzheimer’s disease. He has won prizes from the RANZCP in Old Age Psychiatry and Consultation-Liaison Psychiatry, and he has received research funding from the RBWH Foundation, the RANZCP Young Investigator Grant, Parkinson’s Queensland and Wesley Medical Research. Dr Mosley was awarded an ‘Advance Queensland’ Early Career Fellowship for his Parkinson's disease research and won the postgraduate medal from the Australian Society for Medical Research for findings arising from this project. In 2020, he won the Early Career Psychiatrist award from the RANZCP, which is presented to the fellow producing the most significant piece of research in the five years since fellowship. Currently Dr Mosley's research is funded by the National Health and Medical Research Council (NHMRC) and the Medical Research Future Fund.

If you wish to contact Dr Mosley regarding a clinical matter, please do so via his neuropsychiatry clinic (Neurosciences Queensland) telephone: 07 3839 3688 or email: admin@nsqld.com.au.

Helen’s interest in immune cell interactions across the tissue landscape started during her Master’s and PhD with Dr. Ali Zaid at the Menzies Health Institute, Griffith University. Her PhD focused on defining the role of Interleukin-17 in virus-induced arthritis and exploring immunomodulation as a means of dampening synovial inflammation and damage. There, she was able to specialise in 3D imaging on optically-cleared tissues and high-dimensional flow cytometry. Helen received her PhD in 2022, before immediately starting a Postdoc position under Dr. Emma Gordon and Dr. Larisa Labzin at the Institute for Molecular Biosciences, University of Queensland. Her current research focuses on vascular complications in acute and long COVID-19. Specifically, Helen is developing a novel triple-culture model under air-liquid interface to investigate endothelial dysfunction and explore potential therapeutics in COVID-19.

Antony Moulis is Associate Professor in the School of Architecture, Design and Planning at the University of Queensland, where he teaches and researches across the fields of architecture, urbanism and design. His current research focuses on productive cities and urban retrofit as drivers of positive community change, as featured in the jointly-authored book House, Precinct, Territory: Design Strategies for the Productive City (ORO, 2023) which addresses urban innovation and adaptation in the Asia-Pacific. He is internationally recognised for his work on architectural design practice and patterns of global knowledge transfer. Recent books include the co-authored John Andrews: Architect of Uncommon Sense (Harvard University Press, 2023), which investigates strategies of ecological design in the international context; the sole-authored Le Corbusier in the Antipodes: Art, Architecture and Urbanism (Routledge, 2021) a first account of the modern architect’s reception, encounters and global networks in Australasia, and the co-edited 4-volume anthology, Le Corbusier: Critical Concepts in Architecture (Routledge, 2018), a detailed historiographic survey of writings on, and by, the architect from 1920 to the present. Moulis' research through design involves active collaboration with industry and architectural and urban practices. Co-designed built and speculative projects highlighting micro-urban and resilience strategies for contemporary cities have been awarded, exhibited and published internationally including through journals such as Architecture Australia, The Architectural Review, and GA Houses: the recent books The New Queensland House (Thames & Hudson, 2022) and 33 Documents of Contemporary Australian Architecture (URO, 2022); and exhibited at 2021 Seoul Biennale of Architecture and Urbanism. Moulis oversaw UQ Architecture's participation in the Water Sensitive Cities CRC – a national team of academics and designers developing strategies for urban intensification and green infrastructure. His architectural writing and research spans professional and academic journals, including critical commentary on contemporary architecture.

Awards

The Productive Edge - phorm architecture+design with Silvia Micheli and Antony Moulis

• 2025 Architecture Australia Prize for Unbuilt Work - Special Mention

One Room Tower - phorm architecture+design with Silvia Micheli and Antony Moulis

• House of the Year, Brisbane Region, Australian Institute of Architects, Queensland Awards 2018
• Brisbane Regional Commendation, Residential Architecture - Houses (Alterations and Additions), Australian Institute of Architects, Queensland Awards 2018
• State Award, Residential Architecture - Houses (Alterations and Additions), Australian Institute of Architects, Queensland Awards 2018

Blue Bower - phorm architecture+design with Silvia Micheli and Antony Moulis

• Crossroads X Prize, Seoul Biennale of Architecture and Urbanism 2021
• Greater Brisbane Region Commendation, Australian Institute of Architects, Queensland Awards 2023
• State Commendation for Small Project Architecture – Australian Institute of Architects, Queensland Awards 2023

Memberships and Roles

Past President, Society of Architectural Historians, Australia and New Zealand (SAHANZ) (2013-2015)

Member, Society of Architectural Historians Australia and New Zealand (SAHANZ)

Member, European Architectural History Network

Head of Architecture & Program Director, School of Geography, Planning and Architecture (2004-2008)

PhD project fully funded available now!

My main research area is the control of the spatial and spectral/temporal properties of light, particularly through complex disordered photonics materials such as multimode optical fibers, white paint, fog or biological tissues. The scattering of light through these materials inhibits many applications such as biomedical imaging and optical telecommunications, as it prevents light from being delivered to the desired position(s) at the desired time(s).

To achieve such level of control, I’m using a spatial light modulator in addition to some lab-made software techniques.

Recent research achievements:

• Time reversed optical waves by arbitrary vector spatiotemporal field generation : Nature Communications volume 11, Article number: 5813 (2020)

This work is part of an international collaboration with Nokia Bell Laboratories, Crawford Hill Labs in Holmdel, NJ, USA with Dr Nicolas Fontaine and colleagues.

Lossless linear propagation of waves is linear in time, a principle which can be used to create time reversed waves. Such waves are “pre-scattered” spatio-temporal fields, which propagate through a complex medium (which induces scattering) and arrive after propagation as a desired target field. Time reversed waves were previously demonstrated for relatively lower frequency waves such as water waves, acoustics waves and micro waves. Many attempts have been made to extend these techniques into optics, however the much higher frequencies of optics do not able a direct measurement of the spatio-temporal optical field, flip its time response and send it backwards. A fully time reversed wave is a volumetric field (2 transverse and 1 longitudinal dimensions) with arbitrary amplitude, phase and polarization at every point in space and time. The creation of such fields has not been possible in optics.

We have demonstrated time reversed optical waves with a new device capable of independently controlling all light’s classical degrees of freedom simultaneously. Such device is capable of generating a sequence of arbitrary 2D spatial/polarisation wavefronts at a bandwidth-limited rate (4.4 THz). This new ability to manipulate the full field of an optical beam could be used to control both linear and nonlinear optical phenomena.

Youtube video article: 5 min abstract link which explains the motivation, the setup and some applications. A 75 minutes full technical presentation link presents in depth the results with pedagocial graphics.

The paper was published in "Time reversed optical waves by arbitrary vector spatiotemporal field generation", Nature Communications volume 11, Article number: 5813 (2020) link

Press Release: Physicists create time reversed optical waves, by the UQ News media team link, reposted by different science websites including Phys.org

Conference presentation: I have presented these results at the CLEO virtual conference 2020, the video is accessible for free after registration on the CLEO page (paper SM2H.7) link

• Control of the temporal and polarization response of a multimode fibre: Nature Communications volume 10, Article number: 5085 (2019)

With Dr Joel Carpenter, we have demonstrated how to control light delivery after propagation through a multimode fibre in the temporal domain. Because of the natural mode coupling within a multimode fibre, the impulse response of light gets temporally stretched, over multiple order of magnitudes (picoseconds to nanoseconds) compared to the initial pulse duration (usually ~100 femtoseconds). We notably demonstrated in this work how to maximize the impulse response at arbitrary delay(s), and how to minimize the impulse response, with polarization-resolution.

The results were published in “Control of the temporal and polarization response of a multimode fiber” Nature Communications 10 5085 (2019) link

Press Release: Cutting through fog with laser focus, by the UQ News media team link, reposted by different science websites including Phys.org

Conference presentation: I have presented these results at the CLEO virtual conference 2020, the video is accessible for free after registration on the CLEO page (paper SM1L.3) link

A former Australian Army officer, David’s career in the Australian Intelligence Corps provided wide-ranging experience and specialist qualifications in the intelligence and security domains. He served at the strategic, operational and tactical levels of command providing advice and support to commanders and decision makers both in Australia and deployed on operational service. The culmination of David’s military career came with his appointment as Commandant of Australia’s Defence Intelligence Training Centre in 2003. With command and management responsibility for 145 military and civilian staff, an operational remit for the provision of all intelligence training within Defence and an annual operating budget of $2.5m, this position represents the pinnacle of achievement for an Australian Intelligence Corps officer. David was awarded a Commander Training Command Commendation for his performance of duty in this role.

Since separating from the Army in 2006, David has established and maintained a successful consultancy focussed on the provision of intelligence and security expertise. Levering his knowledge and experience of working as a member of the Australian Intelligence Community for 30 years, David has provided consultancy services to several major Defence projects. He has also developed and delivered intelligence training to organisations including the Australian Federal Police, Victoria’s Office of Police Integrity and the Australian Security Intelligence Organisation.

David possesses a Bachelor of Arts (Honours) degree from the University of New South Wales, a Master of Justice from the Queensland University of Technology and a Doctor of Philosophy from the University of Queensland in which he researched investigative interviewing skill acquisition, transfer and application in the Queensland Police Service. In recent years he has been engaged by the University to design, develop and teach an undergraduate course in Global Security and Regulation and to design the criminology component of the Master of Cyber Security program. He is currently engaged as a lecturer in Cyber Criminology with research interests in countering the possession, production and distribution of Child Exploitation Material and the use of offensive cyber techniques in law enforcement.

Bryan is a graduate in medicine from the University of Queensland and holds a BA (Hons) degree in philosophy from the University of Western Australia. A medical specialist in psychiatry, he is a clinician researcher, who is Conjoint Professor at the Queensland Brain Institute, University of Queensland, and Director of Genetics at the Queensland Centre for Mental Health Research. His primary research interest is the molecular genetics of schizophrenia, and holds a MD degree (University of Queensland) in this field. Since 1990, he has conducted studies, with national and international collaborators, to identify susceptibility genes for this disorder. He is the recipient of grants from the Australian NHMRC and the US NIMH.

The primary research goal is to identify and functionally characterise susceptibility genes for schizophrenia and related disorders. A special focus is on the study of large collaborative samples and ethnically homogeneous populations. Key methodologies used in the lab include genome-wide association studies, next-generation sequencing, transcriptome profiling of post-mortem brain samples, neurocognitive and neuroimaging phenotyping and induced pluripotent stem cells.

Current areas of interest include pharmacogenomics of clozapine treatment response, whole exome sequencing focused on de novo mutations, and the neuroimmunology of schizophrenia

Dr Moyle’s laboratory (www.moylelab.com) uses cutting edge technologies for the synthesis of peptides, protein expression, and protein semi-synthesis to gain insights into the functional roles played by various biochemical pathways, to engineer better protein and peptide therapeutics, and to improve the delivery characteristics of various therapeutic molecules. Specific current areas of interest are detailed below:

1. Subunit Vaccine Development: methods to develop improved vaccines through the combination of recombinant and synthetic approaches to improve immunopotency and tailor immune responses (links to reseach articles on semisynthetic vaccines and peptide vaccines; reviews on vaccine development).
2. Delivery Systems for Nucleic Acid-Based Molecules: multi-component synthetic and recombinant approaches to improve the cellular uptake, and targeted delivery of various oligonucleotide molecules (e.g. siRNA, mRNA, pDNA and CRISPR-Cas9) as an exciting approach to treat or prevent various diseases (links to research articles and reviews).
3. Deciphering the Roles of Post-Translational Modifications: The combination of peptide synthesis and protein semisynthesis to enable the production of large amounts of site-specifically modified species, that can be used to deconvolute the roles played by various post-translational modifications (links to research articles).
4. Peptide/Protein Drugs and Delivery: The study of methods to improve the delivery characteristics of peptide/protein drugs (e.g. poor oral absorption, instability to chemical/enzymatic degradation, and the inability to reach their site/s of action) through chemical engineering approaches.
5. New Approaches for Superbugs: the development of antivirulence approaches, and formulations (e.g. various types of nanoparticles - silver, protein, mesoporous silica), which reduce the ability for microbes to cause disease, and make them more readily treated with antimicrobials, by providing access to synergistic combinations, and reducing the risk of antimicrobial resistance.

Information for Potential Students:

The Moyle lab considers applications from potential students and postdoctoral fellows with an interest in: i) infection control (including subunit vaccine and antimicrobial development); ii) delivery systems for peptide therapeutics; iii) targeted delivery systems; iv) studying the function of posttranslational modifications; and v) delivery systems for nucleic acid-based therapeutics (e.g. siRNA, shRNA, miRNA, mRNA, pDNA and CRISPR-Cas9). If you are interested in working in any of these areas please feel free to contact Dr Moyle (p.moyle@uq.edu.au). Please ensure that you supply an up to date CV; describe why you would like to work in the Moyle lab; provide a listing of publications (preferably with impact factors and citation counts); and indicate what skills you would bring to the lab. Detailed information on our laboratory is available at www.moylelab.com. Preference will be given to students and postdoctoral fellows who have their own funding.

Dr Moyle Biosketch:

Dr Moyle (H-index 30, >2600 citations; >95 publications; 13/8/2024; Google Scholar, ORCID, ResearcherID, and Publons profiles) received a PhD (Dec 2006) and a Bachelor of Pharmacy (Hons I) (Dec 2001) from The University of Queensland (UQ); graduated from the Pharmaceutical Society of Australia pre-registration pharmacist-training course (Nov 2002); and is registered with the Pharmacy Board of Australia. He currently works as an Associate Professor in the UQ School of Pharmacy, where he has been based since 2014.

Dr Moyle works in the fields of medicinal chemistry, chemical biology, and drug formulation, investigating subunit vaccine development, outcomes associated with histone post-translational modifications, and methods to improve the delivery characteristics of oligonucleotide (e.g. siRNA and pDNA), peptide, and protein therapeutics. During his PhD, Dr Moyle developed methods that enabled the synthesis of pure, lipid adjuvanted peptide vaccines, using advanced chemical ligation techniques. In addition, the conjugation of mannose to combined prophylactic/therapeutic human papillomavirus type-16 vaccines, to target dendritic cells, was demonstrated to significantly improve vaccine anti-tumour activity. This work, conducted with leading researchers at the QIMR Berghofer Medical Research Institute (Prof Michael Good & Dr Colleen Olive), established Dr Moyle’s national and international profile in the field of vaccine development, resulting in 11 peer reviewed papers, including top journals in the field (J Med Chem; J Org Chem), as well as 6 review articles and 2 invited book chapters.

Dr Moyle undertook his postdoctoral training in the laboratory of one of the world’s premier chemical biologists, Professor Tom Muir (the Rockefeller University, NY, USA; now at Princeton University, NJ, USA). During this time he developed an extensive knowledge of techniques for protein expression, bioconjugation, bioassays, and proteomics, which represent an essential skill set required for this proposal. As part of this work, Dr Moyle developed novel synthetic routes to generate site-specific ADP-ribose conjugated peptides and proteins. This research was hailed as a major breakthrough in the field, leading to several collaborations, and an exemplary publication in the prestigious chemistry journal JACS. This vast body of work identified the enzyme (PARP10) responsible for mono-ADP-ribosylation of histone H2B, and demonstrated interactions between this modification and several proteins, including BAL, which is associated with B cell lymphomas. In addition, a number of robust chemical methods were developed to enable the synthesis of a complete library of methyl-arginine containing histones, which were incorporated into synthetic chemically-defined chromatin to investigate the site-specific effects of arginine methylation on histone acetylation. This work led to a collaboration with colleagues at Rockefeller to investigate the effects of histone arginine methylation on transcription.

Teaching:

Dr Moyle teaches into the following subjects in the UQ School of Pharmacy.

• PHRM3011 (Quality Use of Medicines) - course coordinator
• PHRM4021 (Integrated Pharmaceutical Development)
• PHRM3021 (Dosage Form Design)
• PHRM2040 (Drug Discovery)

Awards:

2016 - Health and Behavioural Sciences (HABS) faculty commendation for Early Career Citations for Outstanding Contributions to Student Learning (ECCOSL)

2015 - ChemMedChem top 10 cited article of 2013 (link)

2014 - Highest ranked NHMRC development grant (2013; APP1074899)

2013 - Institute for Molecular Biology (IMB) Division of Chemistry and Structural Biology Prize

My current appointment is Director of Kidney Services at Redland Hospitals in Metro South, Brisbane, where I practice as a senior consultant nephrologist.

My research interests are varied and include post-transplant anaemia and iron metabolism, and novel measures of iron status such as hepcidin; improving dialysis outcomes though the implementation of evidence-based guidelines; kidney disease due to thrombotic microangiopathy (particularly aHUS) and the role of inhibitors of the complement system in kidney disease; and the use of honey to prevent infections in dialysis patients.

I am committed to teaching medical students and young nephrologists, and am actively involved in medical education at all levels.

Professor Alison Mudge is a clinician researcher based in the large Department of Internal Medicine and Aged Care at the Royal Brisbane and Women's Hospital. Her applied research focused on understanding and improving inpatient and post-hospital care for frail older Australians through coordinated multidiscipinary approaches. This has involved research and improvement collaborations with multiple healthcare disciplines (e.g. nursing, physiotherapy, nutrition and dietetics, occupational therapy, exercise science) and medical subspecialties (e.g. geriatrics, rehabilitation medicine, cardiology, vascular surgery, palliative care, anaesthetics, gastroenterology).

Alison was inaugural Clinical Director of the Australian Centre for Health Services Innovation (AusHSI) where she advocated strongly for the importance of implementation science approaches, and she has led numerous workshops and mentoring sessions in implementation science and practice including a seminar series within the Queensland Healthcare Improvement Fellowship program. She has been a Metro North Clinician Research Fellow and led competitive grants from NHMRC and MRFF. She advocates for clinician scientists and for authentic consumer engagement in research and service improvement, and is a highly respected undergraduate and gradute educator. She has served on the steering committee for leading Queensland clinical networks inlcuding the Statewide Older Persons's Health Clinical Network and Queensland Dementia, Ageing and Frailty Network, advocating successfully for changes to policy and practice to improve health and wellbeing of older Queenslanders.

Jochen’s research focusses on monitoring of trace organic pollutants, including pioneering work on sources, fate, monitoring techniques (including development of passive sampling techniques) and trends in human exposure to trace contaminants. More recently his group has been leading research in the field of wastewater epidemiology.

Jochen joined QAEHS in 1997 and was awarded an ARC Future Fellowship in 2012 to understand changes in chemical exposure through integrative sampling and systematic archiving. As part of his research program at QAEHS he has lead numerous national and international studies, such as Australia's National Dioxin Program, the Brominated Flame Retardant Program and a major study to investigate bush-fire emissions (the results of which are included in the UNEP Toolkit). He works closely with governments (state, federal and international including UNEP) on the development of systematic monitoring strategies, including for protection of the Great Barrier Reef. As part of his Future Fellowship, he has established an extensive sample archive, the Australian Environmental Specimen Bank (ESB), to allow retrospective analysis of changes in pollutant exposure in Australia.

Jochen’s work on passive samplers, bioanalytical techniques for emerging chemicals and wastewater epidemiology has received support from ARC and numerous industry partners.

I am a bioinformatician with over thirteen years of experience integrating biochemistry and chemistry with advanced computational techniques. My research interests include biologics design, integrating machine learning (ML) and molecular dynamics (MD) to optimise peptide therapeutics. His research focuses on developing and refining peptide drug candidates with enhanced potency, stability, and cell permeability. He employs novel molecular dynamics techniques for optimal peptide-receptor conformational searches that enable robust rational and AI-driven design. Leveraging advanced MD simulations, he explores peptide-receptor dynamics to guide binding and selectivity. I collaborate with industry partners, including AstraZeneca and Novo Nordisk.

Previously, at the Queensland University of Technology, I spearheaded projects on CRISPR-edited bananas funded by major commercial partners Fresh DelMonte and Hort Innovation Australia. My responsibilities included the computational identification and validation of disease susceptibility genes as targets for CRISPR-Cas9 editing. Notably, I contributed to deciphering mechanisms of resistance of QCAV-4, that led to the regulatory approval of the first genetically modified crop for commercial production in Australia. This underscores my ability to translate complex bioinformatics and genomics research that drives commercial outcomes.

My expertise in plant genomics, analysing large, complex, repeat-rich genomes, has equipped me with the skills necessary to tackle the complexities of drug design. These challenges parallel those in drug discovery, where understanding complex molecular interactions and competing trade-offs in engineering drug qualities is challenging.

Novel drug targets under research include Restless Leg Syndrome, Plasmodium falciparum, conotoxins targeting sodium and calcium channels, and theta defensin biosynthesis genes. Additionally, I bias peptide drug designs for potential production in plants. This approach hopes to provide cheaper drugs for developing economies and promote greener chemistry, leveraging plants' natural capabilities to produce complex molecules sustainably and cost-effectively.

PhD project opportunities available

A CEO and former Parliamentarian who has held five Chief Executive Officer appointments and has three decades of experience in industry bodies.

Chief Executive Officer of AUSVEG (2009 – 2016), Chairman and Director of Capital Link (Canberra) Pty Ltd (2003 – 2004), National Executive Director of Australian Hotels Association (1992 – 2003), Director (Dental Programmes) Worldwide for Wm Wrigley Jr. Company (1987 – 1989), Chief Executive Officer of Confectionery Manufacturers of Australia (1983 – 1987), Deputy Director and Federal Director of the Advertising Industry Employers’ Association (1981 – 1983)

Elected to the ACT Legislative Assembly (2004 – 2008) and served, in addition to other positions, as Deputy Opposition Leader, Shadow Treasurer and was Chair of the Standing Committee on Public Accounts.

Numerous Board and Advisory Committee appointments, including as Trustee of HOST PLUS Superannuation, Commonwealth Ministerial Advisory Committees on a range of matters including Horticulture, Tourism, Alcohol, and Gambling, and a number of university committees.

Adjunct Professor, Faculty of Business, Economics and Law, University of Queensland (2004 – present).

Dr Samantha Mulcahy is the Research Program Manager for the Health and Wellbeing Centre for Research Innovation (HWCRI) and the Queensland Centre for Olympic and Paralymic Studies (QCOPS) and is an affiliate researcher at the School of Human Movement and Nutrition Sciences at The University of Queensland. Dr Mulcahy leads strategic operations and management across the research programs which include the UQ HERA Program: The 360-Kids Community Network.

Dr Mulcahy's program of research includes how behaviour change occurs and how behaviour change strategies can be used to achieve effective outcomes in sitting reduction interventions. She is an expert in the field of workplace sedentary behaviour and the use of behaviour change strategies to achieve changes in health behaviours including physical activity and sedentary behaviour. She holds a Masters in Public Health (Health Promotion and Disease Prevention) and has extensive experience in partnership and stakeholder engagement and management of complex multi-year funded research projects and consultancies.